Why It Matters
Sirona Strategies LLC filed a lobbying registration for Innovaccer Inc. on Oct. 27, covering Medicare/Medicaid and resuming the company's federal lobbying after a gap that followed the termination of its prior firm, Mason Street Consulting LLC, on June 30, 2025. All six prior filings listed Health Issues with "Artificial Intelligence in Healthcare" as the specific issue; the new registration lists Medicare/Medicaid with no specific issue stated, marking a shift in focus.
The lobbying team is composed of Kristen McGovern, partner at Sirona Strategies. McGovern previously served as a presidential management fellow at the Department of Health and Human Services from 2008 to 2010, and replaces Susan Zook, who handled all six earlier filings through Mason Street Consulting LLC.
By the Numbers
The 2025 second-quarter termination filing lists $30,000, and earlier reports show $30,000 in the first quarter of 2025; $30,000 in the fourth quarter of 2024; $30,000 in the third quarter of 2024; $30,000 in the second quarter of 2024; and $20,000 in the first quarter of 2024. The new registration, however, carries a $0 filing amount.
Broader Context
Innovaccer describes itself as serving providers, payers and government organizations with a healthcare data and AI platform, according to Business Wire. Meanwhile, the Centers for Medicare and Medicaid Services (CMS) named Innovaccer a participant in its Wasteful and Inappropriate Service Reduction (WISeR) model, a six-year prior-authorization program for Original Medicare that began Jan. 1, with Innovaccer assigned to Ohio.
Competitive Landscape
Ennoble Care LLC hired Venn Strategies LLC on Oct. 20 to lobby on Medicare/Medicaid and Health Issues, while Scout hired DLA Piper LLP (US), also on Oct. 20, to lobby on the same issues. Two days later, Mabel hired Pittman Policy Strategies LLC to lobby on Medicare/Medicaid and Health Issues.
The Bottom Line
Innovaccer Inc. has filed a new client registration more than a year after its prior firm, Mason Street Consulting LLC, was terminated, ending a gap in their lobbying history and marking an issue shift to focus on Medicaid and Medicare.
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article
